Evidence map›Paper›PMID 25337149›Full record

ArticleBiotechnology for biofuels2014

Engineering towards a complete heterologous cellulase secretome in Yarrowia lipolytica reveals its potential for consolidated bioprocessing.

Hui Wei, Wei Wang, Markus Alahuhta, Todd Vander Wall, John O Baker, Larry E Taylor, Stephen R Decker, Michael E Himmel, Min Zhang

Open access · goldAbstract read
In one paragraph

Article in Biotechnology for biofuels, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Disruption of theFrontiers in microbiology · 2021
    Article
  8. EngineeringBiotechnology for biofuels · 2020
    Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Developing cellulolyticBiotechnology for biofuels · 2018
    Article
  14. Alternative Substrate Metabolism inFrontiers in microbiology · 2018
    Review
  15. Article
  16. Article
  17. Article
  18. Conferring cellulose-degrading ability toBiotechnology for biofuels · 2017
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Hui WeiBiosciences Center, National Renewable Energy Laboratory, Golden, CO 80401 USA.
Wei WangBiosciences Center, National Renewable Energy Laboratory, Golden, CO 80401 USA.
Markus AlahuhtaBiosciences Center, National Renewable Energy Laboratory, Golden, CO 80401 USA.
Todd Vander WallBiosciences Center, National Renewable Energy Laboratory, Golden, CO 80401 USA.
John O BakerBiosciences Center, National Renewable Energy Laboratory, Golden, CO 80401 USA.
Larry E TaylorBiosciences Center, National Renewable Energy Laboratory, Golden, CO 80401 USA.
Stephen R DeckerBiosciences Center, National Renewable Energy Laboratory, Golden, CO 80401 USA.
Michael E HimmelBiosciences Center, National Renewable Energy Laboratory, Golden, CO 80401 USA.
Min ZhangNational Bioenergy Center, National Renewable Energy Laboratory, Golden, CO 80401 USA.
National Renewable Energy Laboratory · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundYarrowia lipolytica is an oleaginous yeast capable of metabolizing glucose to lipids, which then accumulate intracellularly. However, it lacks the suite of cellulolytic enzymes required to break down biomass cellulose and cannot therefore utilize biomass directly as a carbon source. Toward the development of a direct microbial conversion platform for the production of hydrocarbon fuels from cellulosic biomass, the potential for Y. lipolytica to function as a consolidated bioprocessing strain was investigated by first conducting a genomic search and functional testing of its endogenous glycoside hydrolases. Once the range of endogenous enzymes was determined, the critical cellulases from Trichoderma reesei were cloned into Yarrowia.

resultsInitially, work to express T. reesei endoglucanase II (EGII) and cellobiohydrolase (CBH) II in Y. lipolytica resulted in the successful secretion of active enzymes. However, a critical cellulase, T. reesei CBHI, while successfully expressed in and secreted from Yarrowia, showed less than expected enzymatic activity, suggesting an incompatibility (probably at the post-translational level) for its expression in Yarrowia. This result prompted us to evaluate alternative or modified CBHI enzymes. Our subsequent expression of a T. reesei-Talaromyces emersonii (Tr-Te) chimeric CBHI, Chaetomium thermophilum CBHI, and Humicola grisea CBHI demonstrated remarkably improved enzymatic activities. Specifically, the purified chimeric Tr-Te CBHI showed a specific activity on Avicel that is comparable to that of the native T. reesei CBHI. Furthermore, the chimeric Tr-Te CBHI also showed significant synergism with EGII and CBHII in degrading cellulosic substrates, using either mixed supernatants or co-cultures of the corresponding Y. lipolytica transformants. The consortia system approach also allows rational volume mixing of the transformant cultures in accordance with the optimal ratio of cellulases required for efficient degradation of cellulosic substrates.

conclusionsTaken together, this work demonstrates the first case of successful expression of a chimeric CBHI with essentially full native activity in Y. lipolytica, and supports the notion that Y. lipolytica strains can be genetically engineered, ultimately by heterologous expression of fungal cellulases and other enzymes, to directly convert lignocellulosic substrates to biofuels.

Indexed as

Advanced biofuelsCell consortiaCellobiohydrolase ICellobiohydrolase IICellulaseEndoglucanase IIHeterologous expressionOleaginous yeastYarrowia lipolytica

Identifiers

PMID25337149
PMCPMC4203959
OpenAlexW1979020786

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.